The first US clinical trial of using an in-brain chip to fight opioid addiction is now underway

Opioid addiction is easily one of the top widespread healthcare issues facing the U.S., and research indicates we’re nowhere near achieving any kind of significant mitigating solution. But a team of medical researchers working at the West Virginia University Rockefeller Neuroscience Institute (RNI) and West Virginia University Medicine (WVU) are beginning a new clinical trial of a solution that uses brain-embedded technology to potentially curb opioid addiction in cases that have resisted other methods of treatment. A team of neurosurgeons from RNI and WVU successfully implanted what’s called a “deep brain simulation” or DBS device into the brain of a 33-year-old man, the first person to participate in the trial. The DBS device consists of a number of tiny electrodes, …

Alexa, where are the legal limits on what Amazon can do with my health data?

The contract between the UK’s National Health Service (NHS) and ecommerce giant Amazon — for a health information licensing partnership involving its Alexa voice AI — has been released following a Freedom of Information request. The government announced the partnership this summer. But the date on the contract, which was published on the gov.uk contracts finder site months after the FOI was filed, shows the open-ended arrangement to funnel nipped-and-tucked health advice from the NHS’ website to Alexa users in audio form was inked back in December 2018. The contract is between the UK government and Amazon Digital Services, Delaware) —In , when the government officially announced the Alexa-NHS partnership, its PR provided a few So it turns out the …

Arceo.ai raises $37 million to expand cyber insurance coverage and access

Critical cyber attacks on both businesses and individuals have been grabbing headlines at an alarming rate. Cybersecurity has moved from a background risk for enterprises to a critical day-to-day threat to business operations, forcing executive teams to pour time and hundreds of billions in capital into monitoring and prevention efforts. Yet even as investment in security ticks up, the frequency and cost of cybercrime to businesses continues to rapidly accelerate, with the World Economic Forum estimating the economic loss due to cybercrime could reach $3 trillion by 2020. More companies are now turning to cyber insurance as a means of mitigating financial exposure. However, for traditional insurers, cybersecurity remains a relatively nascent and unfamiliar issue, requiring risk-assessment data points and …

This Woman Wrote Down Lists Of Ingredients Of US And UK Products, And The Difference Is Disturbing

This difference in product ingredients is most notable when going to the United Kingdom from the United States or vice versa. And let me tell you, it’s shocking when you sit down and compare some of the products from the two countries. That’s exactly what American author and food industry critic Vani Hari, better known as Food Babe, did. Read on for Bored Panda’s interview with Food Babe! foodbabe.com | Instagram | YouTube McDonald’s French Fries Image credits: If you’re living in the US, then the fries you order at McDonald’s might have more than just natural vegetable oil and salt used in the cooking process. While the Quaker instant oatmeal you make yourself for breakfast is also much, much …

UKs health data guardian sets a firm line for app development using patient data

The UK’s health data watchdog, the National Data Guardian (NDG), has published correspondence between her office and the national privacy watchdog which informed the ICO’s finding in 2017 that a data-sharing arrangement between an NHS Trust and Google-owned DeepMind broke the law. The exchange was published following a Freedom of Information request by TechCrunch. In fall 2015 the Royal Free NHS Trust and DeepMind signed a data-sharing agreement which saw the medical records of 1.6 million people quietly passed to the AI company without patients being asked for their consent. The scope of the data-sharing arrangement — ostensibly to develop a clinical task management app — was only brought to light by investigative journalism. That then triggered regulatory scrutiny — …

Researchers spotlight the lie of anonymous data

Researchers from two universities in Europe have published a method they say is able to correctly re-identify 99.98% of individuals in anonymized data sets with just 15 demographic attributes. Their model suggests complex data sets of personal information cannot be protected against re-identification by current methods of “anonymizing” data — such as releasing samples (subsets) of the information. Indeed, the suggestion is that no “anonymized” and released big data set can be considered safe from re-identification — not without strict access controls. “Our results suggest that even heavily sampled anonymized datasets are unlikely to satisfy the modern standards for anonymization set forth by GDPR [Europe’s General Data Protection Regulation] and seriously challenge the technical and legal adequacy of the de-identification …

Using full-body MRIs, Ezra can now detect 11 cancers in men and 13 in women

When Ezra first launched about six months ago, the company was using magnetic resonance imaging machines to test for prostate cancer in men. But the company’s founder, Emi Gal, always had a larger goal. “One of the biggest problems in cancer is that there’s no accurate, fast, painless way to scan for cancer anywhere in the body,” Gal said at the time of his company’s debut. It’s hard to overstate how vitally important early cancer screening is for patients. The American Cancer Society estimates 1.7 million new cases of cancer diagnosed in the U.S. in 2019. For 600,000 people that diagnosis will be a death sentence. Roughly half of cancer patients are detected in the late stage of the disease …

Biofourmis raises $35M to develop smarter treatments for chronic diseases

Biofourmis, a Singapore-based startup pioneering a distinctly tech-based approach to the treatment of chronic conditions, has raised a $35 million Series B round for expansion. The round was led by Sequoia India and MassMutual Ventures, the VC fund from Massachusetts Mutual Life Insurance Company. Other investors who put in include EDBI, the corporate investment arm of Singapore’s Economic Development Board, China-based healthcare platform Jianke and existing investors Openspace Ventures, Aviva Ventures and SGInnovate, a Singapore government initiative for deep tech startups. The round takes Biofourmis to $41.6 million raised to date, according to Crunchbase. This isn’t your typical TechCrunch funding story. Biofourmis CEO Kuldeep Singh Rajput moved to Singapore to start a PhD, but he dropped out to start the …

GetYourGuide picks up $484M, passes 25M tickets sold through its tourism activity app

As we swing into the summer tourist season, a company poised to capitalise on that has raised a huge round of funding. GetYourGuide — a Berlin startup that has built a popular marketplace for people to discover and book sightseeing tours, tickets for attractions and other experiences around the world — is today announcing that it has picked up $484 million, a Series E round of funding that will catapult its valuation above the $1 billion mark. The funding is a milestone for a couple of reasons. GetYourGuide says it is the highest-ever round of funding for a company in the area of “travel experiences” (tours and other activities) — a market estimated to be worth $150 billion this year …